# Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Ulcerative Colitis and Crohn Disease

> **NCT07383597** · NA · NOT_YET_RECRUITING · sponsor: **Efferon JSC** · enrollment: 40 (estimated)

## Conditions studied

- Crohn Disease
- Ulcerative Colitis
- Inflammatory Bowel Diseases

## Interventions

- **DEVICE:** Efferon LPS

## Key facts

- **NCT ID:** NCT07383597
- **Lead sponsor:** Efferon JSC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2027-09-01
- **Final completion:** 2028-03-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07383597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07383597, "Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Ulcerative Colitis and Crohn Disease". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07383597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*